The global mass spectrometry market size reached USD 4.36 Billion in 2021 and is expected to register a revenue CAGR of 6.1% during the forecast period, according to latest analysis by Emergen Research. Increased spending by pharmaceutical companies on research & development activities is a major factor driving market revenue growth. These research activities are also facilitating developments and drawing in investments in biopharmaceutical and personalized medicine. Pharmaceutical and biotechnology sectors account for 18.9% of total global research & development expenditure, according to the 2018 European (EU) Industrial Research & Development Investment Scoreboard. Mass spectrometry is used extensively in the pharmaceutical industry, ranging from drug discovery to late-stage development and clinical trials. As a result, increasing funding in pharmaceutical and biotechnology industries is expected to continue to support revenue growth of the market over the forecast period.
The Mass Spectrometry Marketplace Report offers wide-ranging information and facts about the Mass Spectrometry market pertaining to market size, market share, growth influencing factors, opportunities, and current and emerging trends. The report is formulated with the updated and latest information of the global Mass Spectrometry market further validated and verified by the industry experts and professionals. The Global Mass Spectrometry Market report contains historical, current, and forecast estimation of the revenue generation and profits for each segment and sub-segment of the Mass Spectrometry market in each key region of the world. The report additionally sheds light on the emerging growth opportunities in the business sphere that are anticipated to bolster the growth of the market.
Get a sample of the report @https://www.emergenresearch.com/request-sample/1239
Some Key Highlights From the Report
- Hybrid mass spectrometry segment accounted for significantly robust revenue share in 2021. High investments in providing solutions that enable end-users to decipher complex mixtures is a key factor contributing to revenue growth of this segment. On 15 June 2022 for instance, Thermo Fisher Scientific, which is a leading manufacturer of innovative medical technologies announced offering its Direct Mass Technology mode to enable simultaneous charge detection for analysis of previously unmeasurable analytes. Also, it will complement laboratories and medical research institutes by providing proteomics and aid in deciphering complex mixtures of large macromolecules. Increasing demand can also be attributed to the various greenfield projects executed in countries such as India and China.
- Life science research segment accounted for significantly large revenue share in 2021. Strategic initiatives are undertaken in various countries due to increasing prevalence of chronic diseases and significant investments being made by biopharmaceutical companies in the formulation of new drugs. These factors are driving revenue growth of this segment to a major extent. In addition, companies are providing innovative solutions and investing in the manufacturing of medical technologies that aid medical industry professionals in simplifying diagnostic and treatment processes. This is another factor contributing to revenue growth of this segment.
- Pharmaceutical Industry segment accounted for significantly large revenue share in 2021. Rising investments in improving the sensitivity and resolution of these instruments is a key factor driving revenue growth of this segment. Mass spectrometry is a powerful analytical tool that serves various applications in pharmaceutical and biomedical fields. Also, it has opened new dimensions in the analysis of pharmaceuticals and complex metabolites of biological systems. When compared to other conventional analysis techniques, mass spectrometry is the only one for molecular weight determination, through which users can predict the molecular formula.
- Market in North America accounted for largest revenue share in 2021. Increasing presence of companies such as Thermo Fisher Scientific, Agilent Corporation, and others is a key factor driving revenue growth of the market in this region. These companies are investing significantly in research & development activities and developing new resins for the isolation and purification of vaccines. In addition, initiatives are being undertaking to spread awareness regarding new and advanced spectrometry products and technology.
- On 10 December 2021, Shimadzu Corporation, which is a global supplier of analytical or measuring instruments and industrial machinery headquartered in Kyoto, Japan, announced entering the high-end market by introducing various new models of analytical balances. The new AP-AD series models not only provide excellent performance, such as fast weighing times, high measurement stability, and minimized errors, but also include new convenience features, such as automatic doors and touchless sensors. These sensors allow the entire range of weighing operations to be performed without touching the main unit’s operating panel, which prevents infection and reduces the risk of foreign matter contaminating analytical samples. In addition, the new series includes an ionizer for removing static electricity from samples and containers, as well as a movable internal windbreak plate for reducing weighing times.
Leading Companies of the Mass Spectrometry Industry and Profiled in the Report are:
Thermo Fisher Scientific, Sciex, Agilent Technologies, Waters Corporation, Shimadzu Corporation, Bruker, Jeol Ltd., Teledyne FLIR LLC, MKS Instruments, Analytik Jena GmbH, Applied Rigaku Technologies, Inc., and Kore Technology.
To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/mass-spectrometry-market
Analysis of the segments and their growth projection is carried out by extensive historical and current analysis of the market scenario. Further, the report offers details about the factors and features of the Mass Spectrometry market expected to boost the growth of the industry in the coming years.
Emergen Research has segmented the global mass spectrometry market on the basis of technology, application, end-use, and region:
- Technology Outlook (Revenue, USD Billion; 2019-2030)
- Hybrid Mass Spectrometry
- Single Mass Spectrometry
- Others
- Application Outlook (Revenue, USD Billion; 2019-2030)
- Life Science Research
- Drug Discovery
- Environmental Testing
- Food Testing
- Clinical Diagnostics
- Others
- End-Use Outlook (Revenue, USD Billion; 2019-2030)
- Pharmaceutical Industry
- Biotechnology Industry
- Research & Academic Institutes
- Food & Beverages Industry
- Others
Regional Analysis:
The report sheds light on the region expected to dominate the Mass Spectrometry market in the coming years. The report estimates the market size in terms of volume and value and offers an accurate estimate of the market share each region is anticipated to hold during the forecast period. The report analyzes the spread of the Mass Spectrometry market in key geographies covering North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The regional analysis offers an idea about the production and consumption pattern, import/export, supply and demand ratio, revenue contribution, market share and size, and the presence of prominent players in each region.
Request customization of the report @https://www.emergenresearch.com/request-for-customization/1239
The report covers key points of the market, including the standards, regulations, and policy changes applied by the government on the industry for the coming years. The report encompasses thorough research carried out by the application of advanced analytical tools such as SWOT analysis and Porter’s Five Forces analysis to pinpoint the growth trends and patterns. Factors likely to influence the growth of the market, current trends, opportunities, restraining factors, and business landscape are discussed in-depth in the market study.
Key Questions Answered in the Report:
What is the growth rate of the Mass Spectrometry market? What is the anticipated market valuation of Mass Spectrometry industry by 2030?
What are the key growth driving and restraining factors of the Mass Spectrometry market?
Who are the prominent players operating in the market? What are the key strategies adopted by these companies?
What are the key opportunities and growth prospects of the Mass Spectrometry industry over the forecast period?
Which region is expected to show significant growth in the coming years?
Click here to Buy Now @https://www.emergenresearch.com/select-license/1239
Thank you for reading our report. Please connect with us to know more about the report or for requesting the customization of the report. Our team will ensure the report is best suited to your requirements.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Media Contact
Company Name: Emergen Research
Contact Person: Eric Lee
Email: Send Email
Phone: +1 (604) 757-9756
Address:14671 110 Avenue Surrey, British Columbia, V3R2A9
City: Surrey
State: British Columbia
Country: Canada
Website: https://www.emergenresearch.com/industry-report/mass-spectrometry-market